News

Filter by year

November 3, 2023

ExCellThera announces new UM171 data to be presented at ASH 2023

ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and fitness, announced today several UM171 presentations, including an oral session on new data from Phase 2 studies of investigational UM171 cell therapy in high-risk blood cancer patients...

Read more

September 18, 2023

ExCellThera to present at the 2023 Cell & Gene Meeting on the Mesa Conference

ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today that David Millette, CEO, will present in person at the annual Cell & Gene Meeting on the Mesa conference to be held on October 10-12, 2023, at the Park Hyatt Aviara Resort in Carlsbad, California.

Read more

September 12, 2023

UM171 cell therapy demonstrates improved outcomes compared to cord and matched unrelated donor peripheral blood transplants in real-world setting

ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today findings from a safety and efficacy retrospective analysis comparing outcomes of patients treated with ECT-001 (UM171-expanded) Cell Therapy in a Phase 1/2 trial to those treated with cord blood and matched unrelated donor peripheral blood stem cell transplants.

Read more